<DOC>
	<DOCNO>NCT02127879</DOCNO>
	<brief_summary>The main purpose study determine whether intensive repetitive transcranial magnetic stimulation ( I-rTMS ) effective treatment negative symptom schizophrenia patient whether positive influence cognitive function , social function , quality life , alpha frequency cortical silent period change . Also , study provide data safety tolerability I-rTMS treatment schizophrenia patient .</brief_summary>
	<brief_title>Intensive Transcranial Magnetic Stimulation Negative Symptoms Schizophrenia</brief_title>
	<detailed_description>Patients undergo 5x EEG safety research reason study . Stimulation coil location ( left DLPFC ) determine magnetic resonance imaging ( 1,5T , 3D- TFE , voxel size 1 x 1 x 1 mm , Intera MR scanner ) stereotactic neuronavigation ( Brainsight Frameless ) . Patients evaluate several psychiatric scale . Positive negative symptom scale ( PANSS ) apply first stimulation , end every stimulation day two week last stimulation ( total 6 ) . Other psychiatric evaluation use Clinical global impression ( CGI ) , Sheehan disability scale ( SDS ) , Personal social performance scale ( PSP ) Montgomery-Asberg Depression Scale ( MADRS ) , Calgary depression scale schizophrenia ( CDSS ) ; ( MADRS CDSS exclusion depression ) . These scale use start first stimulation , completion two week last test .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Signed informed consent , patient must able willing participate research study , Undergo examination international neuropsychiatric questionnaire MINI PLUS confirm diagnosis schizophrenia schizophrenic illness duration longer one year , stable consistent drug treatment least two week prior rTMS treatment persistent negative symptom without psychiatric comorbidity ( like depression , mania , anxiety disorder , personality disorder , etc . ) foreground illness The sum negative score range Positive negative symptom score ( PANSS ) must 20 point high least one item area negative symptom ( N1N7 ) must â‰¥ 4 point ( least moderate , clinically significant symptom ) , improvement negative symptomsum ( measure PANSS ) must 10 % low last two week rTMS stimulation . involuntary stay psychiatric clinic recruitment patient ; clinically relevant unstable medical condition ; factor incompatible use rTMS , pacemaker , heart pump metal implant ; history epileptic seizure presence epileptic activity document basis EEG current treatment anticonvulsant act drug anticonvulsant , benzodiazepine ( 10mg/D less diazepam equivalent dosage benzodiazepine ) ; lack cognitive skill participation ; clinically relevant psychiatric comorbidity ( axis 1 diagnosis ) detect use MINI Plus , include current abuse drug alcohol ; heart attack traumatic head injury anamnesis Patient unable undergo brain MRI Acute risk suicide ; knowledge Czech language level allow fill require test battery ; pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Repetitive Transcranial Magnetic Stimulation</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Negative symptom</keyword>
	<keyword>Intensive</keyword>
	<keyword>Transcranial Magnetic Stimulation , Repetitive</keyword>
</DOC>